NasdaqGS:UPBBiotechs
Assessing Upstream Bio (UPB) Valuation After Recent Share Price Volatility
Event context and recent stock performance
Upstream Bio (UPB) has drawn investor attention after a sharp move in its share price, with the stock down about 13% on the day and weaker over the past week and month.
Those short term moves come against a stronger past year, where total return sits around 75%. This raises questions about how investors are weighing the company’s clinical stage respiratory pipeline in relation to its financial profile and recent trading volatility.
See our latest...